1.
R Invernizzi, A Pecci, G Rossi, AM Pelizzari, M Giusto, C Tinelli, E Ascari. Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high-risk myelodysplastic syndromes. haematol [Internet]. 1997Nov.1 [cited 2024Nov.24];82(6):660-3. Available from: https://haematologica.org/article/view/1008